Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.
about
Reverse phase protein arrays in signaling pathways: a data integration perspectiveAnalysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker DiscoveryReverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical UseHow may targeted proteomics complement genomic data in breast cancer?Protein Array-based Approaches for Biomarker Discovery in Cancer.Whole proteome analysis of mouse lymph nodes in cutaneous anthraxThe Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.HER-2 assessment in formalin-fixed paraffin-embedded breast cancer tissue by well-based reverse phase protein arrayATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels.Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues.Multiscale analysis of the murine intestine for modeling human diseases.Recent progress in protein profiling of clinical tissues for next-generation molecular diagnostics.Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry Enables Multiplex, Quantitative Pharmacodynamic Studies of Phospho-Signaling.Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA)A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.Rapid, Multiplexed Phosphoprotein Profiling Using Silicon Photonic Sensor Arrays.Precision oncology based on omics data: The NCT Heidelberg experience.Reverse phase protein arrays: mapping the path towards personalized medicine.MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer.Global Conservation of Protein Status between Cell Lines and XenograftsDevelopment of the Theta Comparative Cell Scoring Method to Quantify Diverse Phenotypic Responses Between Distinct Cell Types.Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array.Translational research in oncology--10 years of progress and future prospects.Subtyping of breast cancer using reverse phase protein arrays.Using tissue samples for proteomic studies-critical considerations.Focal Adhesion Kinase (FAK) tyrosine 397E mutation restores the vascular leakage defect in endothelium-specific FAK-kinase dead mice.Proteomic profiling predicts drug response to novel targeted anticancer therapeutics.Next-generation phenotypic screening.Protein microarray applications: Autoantibody detection and posttranslational modification.Emerging power of proteomics for delineation of intrinsic tumor subtypes and resistance mechanisms to anti-cancer therapies.Translating pharmacodynamic biomarkers from bench to bedside: analytical validation and fit-for-purpose studies to qualify multiplex immunofluorescent assays for use on clinical core biopsy specimens.Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.Naturally Inspired Peptide Leads: Alanine Scanning Reveals an Actin-Targeting Thiazole Analogue of Bisebromoamide.Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma.Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.Three-Dimensionally Functionalized Reverse Phase Glycoprotein Array for Cancer Biomarker Discovery and Validation.Estimation of the proteomic cancer co-expression sub networks by using association estimators.Reverse Phase Protein Arrays and Drug Discovery.High-Density Serum/Plasma Reverse Phase Protein Arrays.Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies.
P2860
Q26799716-D782611B-72AC-4E05-A7EA-ACCBF8DFB034Q28080766-F712C3E3-E306-4CCC-B57C-74C429C2471DQ28083256-C08E2C85-4BDE-462C-97B0-3945C918339AQ31140924-B1A7510A-A6B3-46DA-9E08-ADB65D1C9547Q33632268-6A0EE562-16F7-4F1E-B942-E9444DAA3A61Q34374409-96631115-54D6-4B79-A376-B45134FEB852Q35066321-66B863DB-08B4-4FA4-8000-5D0A1B858AEBQ35184966-BD0B92A6-72E0-4B93-B20F-18B72401A99DQ35198369-4BF07159-5BED-4B86-9306-10E9FAF48244Q35574950-8901842F-5E2C-40CE-8138-95A6ACC837AAQ35651919-34A848FF-9F29-4BF9-9AD9-273301680F7CQ35714211-2C2D9B13-6177-4715-84D2-05A65567BBA6Q35926217-3F5EC306-E1D4-4FC9-B5F9-92D9B1CEBF81Q36134032-D97B7170-E952-4018-9A64-9231D3F176ECQ36186223-986E9DB0-A3B5-4F66-90DB-B78FD4FEDBCBQ36227052-773F0539-1312-4920-BE3E-0A90F78A9109Q36396606-900A8460-6414-4937-859E-5EE617214597Q36519831-36F75838-97FF-48CB-9FC0-11B8AA0DADF5Q36586093-21D20CE9-BA02-4F3E-8B29-9B03A6CCBCAEQ37221907-920ECEE9-030E-47C8-A466-3EDEAC66622EQ37240862-74B71D25-28C1-4A06-A411-FB84FF9FF868Q37698595-18D7A2D7-46F2-4370-A78B-EC46653864D1Q38257126-D53D20D9-3B7B-41DF-8CA9-D736A86FCE04Q38268585-4F84A8D3-BE45-47CF-BD5A-22DA1E14B862Q38315127-7F9739D8-5FBA-4B50-A293-4482EE6AA92AQ38706013-079194D6-1FB9-4E71-9538-BA9AC5C1FF19Q38765422-C5D2F6E9-35C7-4CC7-9A1E-E62B09261476Q38846991-70E983E4-E9F1-492D-A852-00C53BB6B0BEQ38907014-A8D8381F-D832-4386-975A-B06E34F14BB9Q38947310-51095484-DD02-4BCB-B12E-884299EEEC39Q38963126-B8684201-43D8-4FE1-881D-DC9A21ECCF20Q38963132-E4BFFC93-B00F-46DE-9BAD-56A78EC3B788Q41673868-971F5807-0157-417C-86E3-4BCB1A5A4F90Q42201989-21348C94-73CD-43F1-A648-62ADF1E06C38Q42375237-6EC2FCC0-EA7E-4198-B7F7-9809A9200AE6Q44452599-048E92E8-AEEE-4F0C-9F6B-E5F52A23B9D0Q46818303-0E7CFFF0-68C9-4F2E-83D3-F9AD9380D12EQ47951500-783824B1-6CBB-4AEA-B668-F28518551367Q48733544-10091DF7-A69E-4ACE-A133-E766425F7500Q52659649-DC4A52F5-F814-48C6-9450-E4DEEAD2D31A
P2860
Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Realizing the promise of rever ...... Phase Protein Array) society.
@ast
Realizing the promise of rever ...... Phase Protein Array) society.
@en
type
label
Realizing the promise of rever ...... Phase Protein Array) society.
@ast
Realizing the promise of rever ...... Phase Protein Array) society.
@en
prefLabel
Realizing the promise of rever ...... Phase Protein Array) society.
@ast
Realizing the promise of rever ...... Phase Protein Array) society.
@en
P2093
P2860
P50
P356
P1476
Realizing the promise of rever ...... Phase Protein Array) society.
@en
P2093
Bryan Serrels
Emanuel F Petricoin
Gordon B Mills
Harvey B Pollard
Jingchun Zhu
Lance Liotta
Leanne de Koning
Michael Pawlak
Rehan Akbani
Satoshi S Nishizuka
P2860
P304
P356
10.1074/MCP.O113.034918
P577
2014-04-28T00:00:00Z